ImmunoPrecise Antibodies Announces Transfer to Nasdaq Capital Market and Extension of Bid Price Compliance Period
1. IPA's Nasdaq transfer application approved, enhancing market exposure. 2. Granted an additional 180-day period to meet the $1.00 minimum bid.